Discover 2,405 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trial opportunities in Baltimore focus on areas such as oncology, dermatological conditions, neurological diseases, and gastrointestinal diseases like irritable bowel syndrome (IBS). The city’s research institutions are recruiting healthy volunteers looking for paid research opportunities or need clinical trials for a specific health condition, offering access to innovative treatments and therapies.
Filter
2
Filter results
Results: 2,405
To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)
for
Economic Hardship, Condomless Sex, Utilization, Health Care
Location: Baltimore MD
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18 - 24
Code: NCT06096324
Recruiting
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Baltimore MD, Fairfax VA, New York NY, New Haven CT,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase 1, Recruiting
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
Location: Baltimore MD, New York NY, Durham NC, Athens OH,
Sponsor: University of British Columbia
Sex: All
Age: 19+
Code: NCT02375295
Recruiting
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
for
Adolescent Idiopathic Scoliosis
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 10 - 16
Code: NCT03935295
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Baltimore MD, Fredericksburg VA, Allentown PA,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase 3, Recruiting
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry